冠脉介入治疗高龄冠心病心绞痛的临床效果及有效率影响分析

Clinical Effect and Effective Effect Analysis of Coronary Intervention for Elderly Patients with Angina Pectoris

目的研究冠脉介入治疗高龄冠心病心绞痛的临床效果及有效率影响,为临床治疗工作的顺利开展提供有价值的参考依据。方法随机将2018年1月—2019年1月该院40例高龄冠心病心绞痛患者分为实验组(20例,应用冠脉介入治疗)、对照组(20例,应用常规药物治疗)。对比两组患者临床治疗效果、一年生存率、并发症发生率、心血管事件发生率。结果实验组临床治疗总有效率18(90%)例比对照组14例(70%)高,临床比较差异有统计学意义(χ^2=4.329,P=0.037)。经比较,实验组一年生存率18例(90%)高于对照组12例(60%),组间对比差异有统计学意义(χ^2=4.480,P=0.028)。实验组心力衰竭发生率1例(5%)(χ^2=4.329,P=0.037)、再发心绞痛0例(0%)(χ^2=7.059,P=0.008)、造影剂肾病1例(5%)(χ^2=5.625,P=0.018)、心律失常发生率0例(0%)(χ^2=5.714,P=0.017)均比对照组6例(30%),6例(30%),7例(35%),5例(25%)低,差异有统计学意义(P<0.05)。实验组各种心血管事件[脑卒中0例(0%)(χ^2=5.714,P=0.017)、心脏性死亡1例(5%)(χ^2=7.025,P=0.008)、非致命性心肌梗死1例(5%)(χ^2=4.329,P=0.037)]临床发病率均低于对照组5例(25%),8例(40%),6例(30%),组间比较差异有统计学意义(P<0.05)。结论临床治疗高龄冠心病心绞痛的过程中,合理引入冠脉介入治疗临床治疗效果显著,且并发症少,治疗安全性高,预后效果明显,生存率与生活质量水平有所提高,具有较高的临床推广与应用价值。

Objective To study the clinical effect and effective effect of coronary intervention on angina pectoris in elderly patients with coronary heart disease,and provide a valuable reference for the smooth development of clinical treatment.Methods From January 2018 to January 2019,40 patients with coronary heart disease and angina pectoris were randomly divided into experimental group(20 cases,with coronary intervention)and control group(20 cases with conventional drug therapy).The clinical treatment effect,one-year survival rate,complication rate,and incidence of cardiovascular events were compared between the two groups.Results The total effective rate of clinical treatment in the experimental group was 18 cases(90%),which was higher than that in the control group 14(70%).The clinical difference was significant(χ^2=4.329,P=0.037).By comparison,the one-year survival rate of the experimental group was 18 cases(90%)higher than that of the control group 12 cases(60%),and the difference between the groups was significant(χ^2=4.480,P=0.028).The incidence of heart failure in the experimental group was 1 cases(5%)(χ^2=4.329,P=0.037),recurrent angina 0(0%)(χ^2=7.059,P=0.008),contrast nephropathy 1 cases(5%)(χ^2=5.625,P=0.018),arrhythmia incidence rate 0 cases(0%)(χ^2=5.714,P=0.017)were compared with the control group 6 cases(30%),6 cases(30%),7 cases(35%),5 cases(25%)was low,and the difference was statistically significant(P<0.05).Various cardiovascular events in the experimental group[stroke 0 cases(0%)(χ^2=5.714,P=0.017),cardiac death 1 cases(5%)(χ^2=7.025,P=0.008),non-fatal myocardial infarction 1 cases(5%)(χ^2=4.329,P=0.037).The clinical incidence rate was lower than that of the control group 5 cases(25%),8 cases(40%),6 cases(30%),and there was statistically significant difference between the groups(P<0.05).Conclusion In the course of clinical treatment of angina pectoris in elderly patients,the clinical introduction of coronary intervention is reasonable,with fewer complications,high treatment safety,obvious prognosis.improved survival rate and quality of life,and higher clinical promotion and application value.